ICD-10-CM Billable Code

M85.021

Fibrous dysplasia (monostotic), right upper arm

Clinical Classification Guidelines

Medical Intelligence & Overview

Fibrous dysplasia is a bone disorder where normal bone is replaced with fibrous tissue, leading to weakened areas prone to deformity or fracture. When this condition affects a single bone, it is called monostotic fibrous dysplasia. Specifically, M85.021 refers to this condition affecting the right upper arm, including the humerus. Although it can occur in any bone, its presentation varies depending on the affected site. In the case of the right upper arm, symptoms may be subtle initially but can progress to noticeable deformities or increased fracture risk.

Causes & Symptoms

Clinical Causes: Genetic mutations: Most cases are caused by a somatic mutation in the GNAS gene, which leads to abnormal bone growth and development. Development during childhood or adolescence: The condition most frequently manifests during these growth periods when bones are still developing. No clear link to environmental factors or lifestyle has been established, suggesting a primarily genetic origin.

Key Symptoms: Localized pain or tenderness in the affected arm Visible deformity or swelling of the upper arm Weakness or reduced mobility in the arm Frequent fractures or bone fragility in the right upper arm Asymptomatic cases identified incidentally during imaging for other issues

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and imaging studies. The process may include: - **Physical Examination:** Checking for deformity, tenderness, swelling, or range of motion limitations. - **Imaging Tests:** X-rays are primary tools revealing characteristic features such as a well-defined, expansile, lytic lesion with a ground-glass appearance in the affected bone. - **Bone Scintigraphy:** To assess the activity level of the lesion. - **Biopsy:** In uncertain cases, a sample of bone tissue is examined histologically to confirm fibrous dysplasia. Laboratory tests are generally not specific but may rule out other bone pathologies.

Treatment Protocols: Management of monostotic fibrous dysplasia aims to relieve symptoms, prevent fractures, and correct deformities. Treatment options include: - **Observation:** Regular monitoring if asymptomatic and lesions are stable. - **Medications:** Bisphosphonates may be prescribed to reduce bone pain and stabilize the bone structure. - **Surgical Intervention:** For deformities, fractures, or persistent pain, procedures such as curettage, bone grafting, or corrective osteotomy might be necessary. - **Lifestyle Adjustments:** Avoiding activities that increase stress on the affected bone can help prevent fractures. Follow-up care is essential for evaluating disease progression and managing complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M85.021 a billable ICD-10 code?
Yes, M85.021 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M85.021?
Clinical documentation must specify the nature of Fibrous dysplasia (monostotic), right upper arm and any associated comorbidities for accurate reporting.

Cite this Clinical Reference